Array BioPharma achieves research milestone in Genentech collaboration

By Elaine Rigoli

Tampa, Fla., April 17 - Array BioPharma, Inc. announced Monday that a research milestone was achieved in its collaboration with Genentech, Inc.

Financial terms of the milestone were not disclosed.

The milestone resulted from the nomination of a clinical candidate and its advancement into regulated safety assessment testing, according to a news release.

Genentech and Array started an oncology collaboration in January 2004 to identify small-molecule development compounds against multiple targets.

Array is entitled to additional milestone payments and potential royalties from Genentech based upon continued success of the program, the release said.

Genentech, located in South San Francisco, Calif., is a biotechnology research company.

Array BioPharma, a Boulder, Colo.-based biopharmaceutical company, develops targeted small-molecule drugs.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.